Unicorn Biotechnologies Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 15

Unicorn Biotechnologies General Information

Description

Developer of bio-reactors designed for cell-based manufacturing. The company uses a modular system with streamlined workflows, connected via cloud computing architecture that seamlessly integrates optimization and scale-up and affordably scales production capacity, enabling clients to produce cultivated meat and reduce their dependence on animals.

Contact Information

Website
www.unicornb.io
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 192 Shoreham Street
  • South Yorkshire
  • Sheffield S1 4SQ
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Vertical(s)
CleanTech, FoodTech, Manufacturing, AgTech, Climate Tech
Corporate Office
  • 192 Shoreham Street
  • South Yorkshire
  • Sheffield S1 4SQ
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Unicorn Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Secondary Transaction - Private Completed Generating Revenue
6. Seed Round 01-Apr-2022 Completed Generating Revenue
5. Accelerator/Incubator 15-Sep-2021 Completed Generating Revenue
4. Seed Round 24-Mar-2021 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2021 Completed Startup
2. Accelerator/Incubator 01-Jan-2020 $105K $105K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Unicorn Biotechnologies’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Unicorn Biotechnologies Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Unicorn Biotechnologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12203549-B1 Method of interfacing nonspecific conduits between thermally insulated gaseous environments Active 03-Feb-2024
US-20250250527-A1 Method of interfacing nonspecific conduits between thermally insulated gaseous environments Pending 03-Feb-2024
WO-2025125899-A2 An integrated system for the automated passaging of anchorage dependent cell cultures Inactive 16-Dec-2023
WO-2025125899-A3 An integrated system for the automated passaging of anchorage dependent cell cultures Inactive 16-Dec-2023
US-12116562-B1 Integrated system for the automated passaging of anchorage dependent cell cultures Active 16-Dec-2023 C12M29/00
To view Unicorn Biotechnologies’s complete patent history, request access »

Unicorn Biotechnologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Unicorn Biotechnologies Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Acequia Capital Venture Capital Minority
Alumni Ventures Venture Capital Minority
Climate Capital Venture Capital Minority
East Innovate Venture Capital Minority
East X Hedge Fund Minority
You’re viewing 5 of 15 investors. Get the full list »

Ready to get started?

Request a free trial

Unicorn Biotechnologies FAQs

  • When was Unicorn Biotechnologies founded?

    Unicorn Biotechnologies was founded in 2020.

  • Where is Unicorn Biotechnologies headquartered?

    Unicorn Biotechnologies is headquartered in Sheffield, United Kingdom.

  • What is the size of Unicorn Biotechnologies?

    Unicorn Biotechnologies has 14 total employees.

  • What industry is Unicorn Biotechnologies in?

    Unicorn Biotechnologies’s primary industry is Biotechnology.

  • Is Unicorn Biotechnologies a private or public company?

    Unicorn Biotechnologies is a Private company.

  • What is Unicorn Biotechnologies’s current revenue?

    The current revenue for Unicorn Biotechnologies is .

  • How much funding has Unicorn Biotechnologies raised over time?

    Unicorn Biotechnologies has raised $2.5M.

  • Who are Unicorn Biotechnologies’s investors?

    Acequia Capital, Alumni Ventures, Climate Capital, East Innovate, and East X are 5 of 15 investors who have invested in Unicorn Biotechnologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process